BMS-P5 free base
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression.
Product Specifications
CAS Number
1550371-22-6
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (529.01 mM)
Smiles
O=C (N1[C@@H] (C) CC[C@@H] (N) C1) C2=CC (OC) =C3C (N=C (C4=CC5=CC=CN=C5N4CC6CC6) N3C) =C2
Molecular Formula
C27H32N6O2
Molecular Weight
472.58
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Scgb3a1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
DUSP2, CT (DUSP2, PAC1, Dual specificity protein phosphatase 2, Dual specificity protein phosphatase PAC-1) (Biotin) discontinued
Mouse Monoclonal KIR2DL1/CD158a Antibody (MM0438-11G25) [CoraFluor 1]
